Serial dilutions are both independent experiments and building blocks of more complex experimental pipelines. Applications can be as simple as generating a standard curve or more complex phenotype characterization across cell culture concentrations. In any application, precise pipetting is required to generate reliable results. Read More

Modern molecular biology, driven by ever progressing technology, continues to deliver impressive and exciting new advancements — larger studies, more powerful therapeutics, and wholly new research questions. Read More

The Swift 2S Turbo DNA Library Kit was fully automated using the Opentrons OT-2 for quick, hands-off, highquality libraries for Illumina Next-Generation Sequencing. Read More

Microbiomics is a burgeoning field with implications for a wide range of topics in human health. Modern sequencing techniques can deliver rich and novel data but are constrained by DNA extraction methods that are difficult, time consuming, and, especially in microbiomics samples, prone to bias. Read More

Enzyme immunoassays (EIAs) or enzyme-linked immunosorbent assays (ELISAs) are widely used analytic tools for detection of a target molecule (e.g., an antigen) in liquid samples for diagnostic or research purposes. Read More

The Opentrons COVID-19 Testing System is a flexible, high-throughput surveillance testing system using OT-2 hardware & validated withZymo reagents to process up to 2,400 samples per day. Read More

The next-generation sequencing (NGS) workflow includes preparing DNA libraries using commercially available and cost-effective DNA preparation kits. Optimizing this workflow by using an automated OT-2 protocol helps to improve the efficiency for DNA library preparation. Read More

The Swift 2S™ Turbo DNA Library Kit was automated with the Opentrons OT-2 for fast and robust preparation of high quality libraries for next generation sequencing. Read More

Using the Opentron’s OT-2 and platform, we demonstrate a highly sensitive, affordable, and hands-off pipeline for PCR-based SARS-CoV-2 testing. Read More

Biologic drugs are the largest and fastest growing segment of the Pharmaceutical industry, with sales of €500bn and an annual growth of 8%.1 Their ability to target diseases with high specificity results in improved safety and effectiveness. However, this increases the cost of manufacturing significantly over their predecessors. Read More